HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Murat Mert Atmaca Selected Research
Murat Mert Atmaca Research Topics
Disease
3
Ischemic Stroke
11/2023 - 01/2020
3
Epilepsia Partialis Continua
01/2018 - 08/2015
3
Status Epilepticus (Complex Partial Status Epilepticus)
12/2017 - 08/2015
2
Epilepsy (Aura)
01/2018 - 12/2017
1
Stroke (Strokes)
11/2023
1
Infections
11/2022
1
COVID-19
11/2022
1
Transthyretin-Related Hereditary Amyloidosis
01/2022
1
Multiple Sclerosis
03/2021
1
Hemorrhage
01/2020
1
Seizures (Absence Seizure)
09/2018
1
Double cortex
12/2017
1
Neoplasms (Cancer)
12/2017
1
Autoimmune Diseases of the Nervous System
12/2017
Drug/Important Bio-Agent (IBA)
3
erucylphosphocholine
IBA
01/2018 - 08/2015
2
Antibodies
IBA
11/2023 - 12/2017
2
ocrelizumab
IBA
11/2022 - 03/2021
2
Levetiracetam (Keppra)
FDA Link
Generic
10/2017 - 08/2015
1
Prealbumin (Transthyretin)
IBA
01/2022
1
Anticonvulsants (Antiepileptic Drugs)
IBA
09/2018
1
Natalizumab (Tysabri)
FDA Link
09/2018
1
N-Methylaspartate (NMDA)
IBA
12/2017
1
gamma-Aminobutyric Acid (GABA)
IBA
12/2017
1
Autoantibodies
IBA
12/2017
1
Phenytoin (Dilantin)
FDA Link
Generic
10/2017
Therapy/Procedure
2
Therapeutics
11/2022 - 11/2021
1
Duration of Therapy
11/2022
1
Thrombolytic Therapy
01/2020